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Introduction
Thoracoabdominal aortic aneurysms (TAAA) have long
proven one of the most challenging clinical scenarios to
confront vascular surgeons. Open repair has traditionally
required extensive aortic dissection, often involving theE-mail address: Tom.Forbes@lhsc.on.ca.
Treatment of Type IV Thoracoabdominal Aneurysms 9thoracic and abdominal cavities, and has resulted in not
insignificant rates of mortality and major morbidity,
including cerebral and cardiovascular events, spinal cord
ischemia and renal dysfunction. Pharmacologic, anesthetic
and surgical adjuncts have been developed in response to
these adverse outcomes and have at least partially miti-
gated their occurrence, but not completely.1
More recently, refinements in surgical technique have
been developed in the efforts to improve these outcomes.
With evolving endovascular technology two major shifts
in surgical approach have led to a hybrid approach,
combining visceral and renal artery debranching with stan-
dard thoracic stent grafts,2 and a totally endovascular
approach, which up until recently has involved a customized
branched or fenestrated endograft.3 Both of these innova-
tions in surgical approach have their place, and some distinct
advantages, and will be discussed by my fellow contributors.
At first glance, the more surgical options there are, the
more confusing the choice of that which is most appro-
priate appears to be. However, an important point requires
repeating prior to entering this discussion, namely the
anatomic extent of the TAAA. The current discussion is
centered on the surgical treatment most appropriate for
Crawford Type IV TAAAs. By definition, these aneurysms are
limited to the abdominal cavity and the aorta below the
diaphragm.4 With the debate confined to this lesion, it is
clear that open repair is the preferable option, with only
a small number of exceptions.Results of Open Repair
Open repair of Type IV TAAAs has a long history of good
outcomes. Because of its limited extent, relative to Type
IeIII, open repair is invariably a one-cavity operation
(abdominal) with supraceliac proximal aortic control, graft
interposition, and renal and mesenteric revascularization in
a manner dictated by the aneurysm morphology and
surgeon preference. Although specific adjuncts that mini-
mize adverse sequelae have been more widely utilized in
Types IeIII TAAAs, they have been used less often with Type
IV’s. Postoperative renal dysfunction has long been
observed to be an independent predictor of mortality
following open TAAA repair,1 and up to 15% of TAAA patients
will exhibit some element of preoperative renal dysfunc-
tion.4 For these reasons the most commonly used adjunct
with open repair of Type IV’s has invariably been renal
perfusion. In a recent report that comprised a total of 509
TAAAs, the Houston group described their choice of
adjuncts and outcomes in 125 Type IV TAAAs.5 Whereas left
heart bypass was used in the majority of Type I and II
thoracoabdominal aneurysms, it was not used in any Type IV
aneurysms. Renal perfusion was employed in the majority
of Type IV’s (98.4%) while celiac or superior mesenteric
artery perfusion was not used in any,5 in contrast to the
preference of some groups.4 Cerebrospinal fluid drainage,
in an attempt to prevent spinal cord ischemic complica-
tions, was used in a quarter (25.6%) of Type IV patients.5
With this approach of open repair of Type IV TAAAs with
selected adjuncts, optimal outcomes are possible. The
recent report from Houston included a 6.4% rate of dialysis
dependent renal failure at the time of discharge, a 1.6%rate of permanent paraplegia, and a perioperative
mortality rate of 8.0%.5 In a multivariate analysis, type IV
TAAAs were independently associated with a lower risk of
an adverse outcome.
However, these results were achieved at a center of
excellence with a long history of experience with thor-
acoabdominal aneurysms. Are these results with open
repair achievable at other centers, with less experience?
This is a question certain to be raised by the other discus-
sants. In a widely quoted paper, statewide outcomes from
California were analyzed, and the UCLA group reported
a 19% thirty day and 31% one year elective mortality rate in
over one thousand thoracoabdominal aneurysms over a ten
year period (1991e2002).6 These sobering results were
achieved at a variety of hospitals, of differing sizes, with
varying experiences and patient volumes. The authors are
the first to admit, however, that this study had several
important limitations. First of all, mortality was the only
outcome measure reported in this database. Information
regarding other important outcomes, including paraplegia
and renal dysfunction, is distinctively lacking in this state-
wide database. Most importantly, in the context of the
current discussion, is the lack of anatomic extent infor-
mation contained in this database. All aneurysms were
grouped together and the results reported are reflective of
a pool of aneurysms of all anatomic extents, Types IeIV.
There is no reason to suggest that this statewide series is
any different from other reported experiences where
approximately 25% of thoracoabdominal aneurysms were
Type IV aneurysms.5 Therefore, it is likely that these Cal-
ifornia results predominantly represent an experience with
more extensive TAAAs with a more minor contribution of
Type IV’s (approximately 25%).Open Repair versus Hybrid Repair
Hybrid repair of TAAA, combining visceral and renal
debranching and endovascular repair, was first reported in
1999.7 Since then several centers have advocated its use
as a less invasive alternative to open repair of TAAAs.
Classically it obviates the need for aortic clamping via
debranching of the visceral aorta with retrograde bypasses
to the mesenteric and renal arteries which are subjected to
sequential ischemia and reperfusion. This is followed by
placement of a standard thoracic endograft across the
aneurysmal visceral aorta at the same sitting, or more
commonly in a staged manner.
Several groups have attempted to compare their
experiences with hybrid repair and open repair of
TAAAs.2,8 The Cleveland Clinic group reported their out-
comes following staged hybrid repair of 13 TAAAs which
were deemed too high risk for open repair.8 Although they
concluded that this approach is feasible, it is not without
its adverse outcomes. Specifically, two of the 13 patients
suffered from paraplegia, 2 required short-term hemodi-
alysis, and 3 of the 13 patients died within 30 days, and
there were 2 instances of late aneurysm related deaths.
It’s important to note that only one of these 13 patients
was a Type IV TAAA.
In a larger analysis the group from Massachusetts General
Hospital (MGH) compared their experience with 23 hybrid
10 T.L. Forbesrepairs with 77 open repairs of thoracoabdominal aneu-
rysms in high-risk individuals.2 Although the hybrid repairs
were performed in higher risk patients, they reported
similar one-year survival rates for open (73%) and hybrid
(68%) cohorts. Reinterventions following hybrid repair were
not infrequent with 22% of hybrid patients developing an
endoleak with three instances requiring an endovascular
reintervention. However, although any comparison of these
approaches is welcomed, the relevance of this experience
to the current discussion is severely limited by the under
representation of Type IV aneurysms in the hybrid cohort.
There were no Type IV aneurysms treated via a staged
hybrid approach in this series.
In the absence of a good comparison of hybrid and open
repair of Type IV aneurysms, we’ll rely on surgical common
sense. Both methods of repair require a large abdominal
exposure, so although the hybrid approach involves an
endovascular component, it is hardly less invasive. The
hybrid approach actually involves a more extensive aortic
repair, often extending into the descending thoracic aorta
with a stent graft, whereas open repair is limited to the
subdiaphragmatic aorta. This extension into the thoracic
aorta, and the resulting occlusion of distal thoracic inter-
costals arteries, may actually increase the risk of spinal
cord ischemia with hybrid repair compared to open repair.
Additionally, with up to 22%2 of hybrid patients developing
an endoleak, this repair may have to be extended even
more proximally, increasing the risk of paraplegia even
further. Another disadvantage of the hybrid approach as it
is currently practiced, is the delay in therapy inherent in
a staged approach. Although probably under-reported in
the literature, most investigators have had a patient
rupture their aneurysm between stages of this procedure.
It is debatable whether a hybrid approach, with
sequential visceral and renal ischemia during debranching,
is less physiologically stressful than supraceliac clamping
and adjunctive perfusion measures. Both involve a measure
of renal and mesenteric ischemia, and, as shown in the MGH
series,2 patients at prohibitive risk of open repair for Type
IV aneurysms do not clearly benefit from a hybrid approach
and should be seriously considered for a nonoperative
approach.
In this comparison of open and hybrid approaches for
Type IV TAAAs there remains little question that open repair
is the preferable operation for patients who are physio-
logically appropriate for an operative intervention. At our
center, this is certainly the preferred option in the vast
majority of cases, with a hybrid repair reserved for patients
with very specific anatomic patterns, usually including
reoperative aortic surgery and more urgent indications.Open Repair versus Endovascular Repair
Admittedly, totally endovascular repair of Type IV thor-
acoabdominal aneurysms is an inherently attractive option.
Since its initial report in 20059 further experience has been
gained with this approach, primarily at selected individual
centers. Although, work has progressed in the development
of a standardized design, the majority of reported experi-
ence involves customized branched and/or fenestrated
devices from a single manufacturer (Cook Medical). Thefenestrations and branches are then mated with their cor-
responding visceral or renal arteries with a combination of
balloon expandable or self-expanding covered stents,
obviating the requirement for visceral ischemia. This is
attractive, especially in higher risk individuals who might
not tolerate thoracic aortic clamping and visceral or renal
ischemia. Inherent in this approach, however, are several
disadvantages, including the development of the necessary
interventional skills that are required, the time period and
cost required for graft planning and manufacturing, and the
limitation of this technology to a subset of anatomically
appropriate patients.
In an important comparative study, the group from the
Cleveland Clinic compared their results following open and
totally endovascular repair of TAAAs.3 In this large study,
over 700 patients were treated with endovascular patients
being older, having more extensive comorbidities, and more
likely to have had previous aortic repairs. Despite this,
mortality at 30 days (5.7% endovascular and 8.3% open) and
one year (15.6% endovascular and 15.9% open) was
comparable. A statistically insignificant trend toward more
frequent spinal cord complications was observed in the
open repair group with extent of repair being an indepen-
dent predictor of spinal cord complications following
multivariate analysis.
Reports such as these, from centers such as the Cleve-
land Clinic, are certainly promising, but it continues to be
premature to recommend a totally endovascular approach
as the preferred method of repair for all Type IV thor-
acoabdominal aneurysms. Generalizability of these results
beyond a relatively small number of international centers
remains a concern, and is hindered by cost, interventional
skill development and regulatory issues in certain parts of
the world. This question of generalizability of an endovas-
cular approach is at least as relevant as those similar
concerns regarding open repair. Although advances have
been made in the development of a standardized stent
graft10 this approach continues to require customized stent
grafts too frequently to permit wider spread adoption and
utilization in a timely fashion.
Several anatomic issues require further elucidation prior
to wider adoption of a totally endovascular approach.
Specific hurdles include tortuous thoracic aortas which can
inhibit accurate endograft delivery and deployment, and
small visceral and renal arteries which can limit long-term
patency of covered stents. Additionally, although the vast
majority of Type IV thoracoabdominal aneurysms are
degenerative in nature, certain proportions are of other
etiologies that offer unique challenges and limitations for
an endovascular approach. In the report from Houston 8.8%
of patients with Type IV TAAAs had a documented connec-
tive tissue disorder or Marfan syndrome while 8% had
a chronic dissection.5 These etiologies can be challenging,
regardless of method of repair, but have unique implica-
tions for endovascular repair including uncertain longer
term outcomes.
Much work has been done in the development of an
endovascular approach, but much more is needed prior to
recommending this repair as the preferred option for Type
IV thoracoabdominal aneurysms. In our practice, open
repair remains the preferred option for Type IV TAAAs, with
a totally endovascular approach reserved with those
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11anatomically appropriate, and physiologically higher risk
patients with moderate sized aneurysms who can tolerate
the time required for customized graft planning and
manufacturing.
Conclusion
When restricting the discussion to Type IV thor-
acoabdominal aneurysms, the choices are clear. In the vast
majority of patients, deemed candidates for repair, open
repair remains the preferred option. Hybrid repairs have
limited applicability and should be reserved for specific
anatomic patterns, usually involving redo aortic surgery and
more urgent presentations. Although promising, wider
adoption of a totally endovascular approach for Type IV
TAAAs is not currently appropriate and this technology
should be reserved for those physiologically higher risk
patients at centers with sufficient experience.
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Numerous comparisons have been conducted between
open repair (OR) and endovascular repair (ER) of aortic
aneurysm including randomized controlled trials (RCT)
involving infrarenal aortic aneurysms. But no such RCT
exists for type IV thoracoabdominal aneurysms (Type IV-
TAA) due to several limitations including poor-risk patients
that are not eligible for randomization, the need for a large
number of patients and surgeons with a high level of
endovascular skills required for branched endovascular
stent-grafts.
Consequently, the authors have to rely on uncontrolled
clinical series comparing these different techniques, i.e.
conventional OR, ER, and hybrid techniques for patients
with variable risk factors.
In this debates limited to Type IV-TAA, Haulon et al.
reported outstanding results in a large series of 231 patients
treated by a fenestrated stent-graft with no intraoperative
mortality, 2.6% of mortality at 30-day, 1% of spinal cord
ischemia (SCI) and no aneurysm rupture at 2-year with the
use of 44 secondary procedures, but generalization of these
excellent results will be difficult to obtain.
Interestingly enough, coming from the same institution,
Greenberg et al.1 reported the results of a consecutive
cohort of patients with thoracic and thoracoabdominal
aneurysms treated electively with ER or OR. In this large
comparative series, the subset of patients with type IV-TAA
demonstrated comparable incidences of 30-day mortality
(4% and 6% for ER and OR respectively) and of SCI (3% and 2%
for ER and OR respectively). However OR was offered more
often to healthier patients. On the basis of this series, it is
clear that ER of type IV TAA is feasible and produces results
similar to OR even in more frail patients.
Considering OR, adjunctive measures such as distal
aortic perfusion, cerebrospinal fluid drainage, intercostal
artery attachment have also helped to reduce the 30-day
mortality, SCI and renal failure rates to 3.4%, 1.4% and 5.4%
respectively with a durable procedure and very low rates
of aneurysm-related complications in the long-term
